User contributions for Palmdoc
From OncoWiki
Jump to navigationJump to search
29 August 2013
- 07:0307:03, 29 August 2013 diff hist +82 m EPOCH-DA →Regimen
- 07:0207:02, 29 August 2013 diff hist +45 N EPOCH-DA Created page with "== Regimen == R-EPOCH-DA: Dose Adjusted EPOCH"
- 06:5306:53, 29 August 2013 diff hist +17 Lymphoma Non-Hodgkin's, Adult →Aggressive NHL
16 August 2013
- 09:3109:31, 16 August 2013 diff hist +1 Clofarabine, cyclophosphamide and etoposide →Regimen current
9 October 2012
- 03:5803:58, 9 October 2012 diff hist +66 Acute Myeloid Leukemia,Adult →Post-remission regimens current
- 03:5703:57, 9 October 2012 diff hist +47 Acute Myeloid Leukemia,Adult →Induction regimens
- 03:5703:57, 9 October 2012 diff hist +1,430 N Cytarabine Idarubicin Vorinostat induction Created page with "==Cytarabine (Cytosar), Idarubicin (Idamycin), Vorinostat (Zolinza) induction== ===Regimen=== *Vorinostat (Zolinza) 500 mg PO TID on days 1-3 *Cytarabine (Cytosar) 150..." current
- 03:5603:56, 9 October 2012 diff hist +1,281 N Cytarabine Idarubicin Vorinostat consolidation Created page with "==Cytarabine (Cytosar), Idarubicin (Idamycin), Vorinostat (Zolinza) consolidation== Preceded by Cytarabine_Idarubicin_Vorinostat_induction therapy. ===Regimen=== *[[Vorin..." current
- 03:5503:55, 9 October 2012 diff hist −116 m Vorinostat →Vorinostat (Zolinza) maintenance current
- 03:5303:53, 9 October 2012 diff hist +938 N Vorinostat Created page with "==Vorinostat (Zolinza) maintenance== Preceded by [[#Cytarabine_.28Cytosar.29.2C_Idarubicin_.28Idamycin.29.2C_Vorinostat_.28Zolinza.29_consolidation|Cytarabine (Cytosar), Idaru..."
- 03:5303:53, 9 October 2012 diff hist +19 Acute Myeloid Leukemia,Adult →Post-remission regimens
8 October 2012
- 03:0203:02, 8 October 2012 diff hist −50 m BEAC →Regimen current
- 03:0203:02, 8 October 2012 diff hist +1,121 N BEAC Created page with "BEAC: '''<u>B</u>'''iCNU, '''<u>E</u>'''toposide, '''<u>A</u>'''ra-C, '''<u>C</u>'''yclophosphamide ===Regimen === ''Autologous blood stem cells are infused on day 0.'' *[[Car..."
- 02:4902:49, 8 October 2012 diff hist +2,934 BEAM →Regimen current
- 02:0002:00, 8 October 2012 diff hist +107 m BEAM →Regimen
- 01:5201:52, 8 October 2012 diff hist −2 m BEAM →Regimen
- 01:4801:48, 8 October 2012 diff hist +1,010 N BEAM Created page with "===Regimen=== ''Day 0 is the day of transplantation.'' *Carmustine 300 mg/m2 IV on day -6 *Etoposide ) 200 mg/m2 IV BID on days -5 to -2 *Cytarabine ) 200 mg/m2 I..."
- 01:4601:46, 8 October 2012 diff hist +4 m Stem Cell Transplantation →Autograft regimens
- 01:4601:46, 8 October 2012 diff hist +19 Stem Cell Transplantation →Autograft regimens
- 01:3901:39, 8 October 2012 diff hist +33 Cytotoxic Regimens →External Links current
30 September 2012
- 03:4103:41, 30 September 2012 diff hist +47 m Main Page →Editors
27 August 2012
- 08:2708:27, 27 August 2012 diff hist +4 APL4 - ALLG →References current
- 08:2408:24, 27 August 2012 diff hist +4 m APL4 - ALLG →References
- 08:2408:24, 27 August 2012 diff hist +3,041 N APL4 - ALLG Created page with "== Regimen == '''Induction''' ATRA 45mg/m2/d PO Days 1-36 in divided doses Idarubicin 12mg/m2/d IV(ages 1-60) Days 2,4,6,and 8 9mg/m2/d IV (ages 61-70) 6mg/m2/d IV (ag..."
- 08:2308:23, 27 August 2012 diff hist 0 Acute Myeloid Leukemia,Adult →APL Regimens
- 08:1008:10, 27 August 2012 diff hist +20 Acute Myeloid Leukemia,Adult →APL Regimens
26 May 2012
- 23:3023:30, 26 May 2012 diff hist −1 m CLAG-M No edit summary current
- 23:2923:29, 26 May 2012 diff hist +443 ATRA plus As203 No edit summary current
- 23:2523:25, 26 May 2012 diff hist +4 m CLAG-M No edit summary
- 23:2423:24, 26 May 2012 diff hist +5 CLAG-M No edit summary
- 23:2423:24, 26 May 2012 diff hist +969 N CLAG-M Created page with "== Indication == Relapsed or refractory acute myeloid leukemia == Regimen == *Cladribine (2-CdA) 5 mg/m2/d iv over 2 hrs d1-5 *Cytarabine (Ara-C) 2 g/m2/d iv over 4 hrs star..."
- 23:2223:22, 26 May 2012 diff hist 0 m Acute Myeloid Leukemia,Adult →Salvage Regimens
- 23:2123:21, 26 May 2012 diff hist +4 m Acute Myeloid Leukemia,Adult →Salvage Regimens
- 23:2123:21, 26 May 2012 diff hist +11 Acute Myeloid Leukemia,Adult →Salvage Regimens
26 February 2012
- 10:0110:01, 26 February 2012 diff hist +65 FOLFIRINOX No edit summary current
- 10:0010:00, 26 February 2012 diff hist +1,094 FOLFIRINOX No edit summary
- 09:5809:58, 26 February 2012 diff hist +38 N FOLFIRINOX Created page with "== Metastatic Pancreatic Cancer =="
- 09:5709:57, 26 February 2012 diff hist +16 Pancreatic Cancer No edit summary current
23 February 2012
- 05:1505:15, 23 February 2012 diff hist −241 m VMP →Multiple Myeloma current
- 05:1405:14, 23 February 2012 diff hist +483 N VMP Created page with "== Multiple Myeloma == Bortezomib 1.3 mg/m2 IV or SC. Given subcutaneously or as a rapid IV bolus over three to five seconds. Days 1, 8, 15, and 22 Melphalan 9 mg/m2 PO dai..."
- 05:0805:08, 23 February 2012 diff hist +12 Multiple Myeloma And Plasma Cell Dyscrasias →Bortezomib regimens
20 February 2012
- 23:5923:59, 20 February 2012 diff hist +591 Cyclophosphamide Bortezomib Dexamethasone →Reference current
- 23:5523:55, 20 February 2012 diff hist +10 m Multiple Myeloma And Plasma Cell Dyscrasias →Bortezomib regimens
- 23:5423:54, 20 February 2012 diff hist +359 Cyclophosphamide Bortezomib Dexamethasone No edit summary
12 February 2012
- 21:4321:43, 12 February 2012 diff hist +10 MediaWiki:Sidebar No edit summary current
- 21:4121:41, 12 February 2012 diff hist −8 MediaWiki:Sidebar No edit summary
- 21:3921:39, 12 February 2012 diff hist −514 Main Page No edit summary
- 14:0414:04, 12 February 2012 diff hist 0 m Talk:Main Page Protected "Talk:Main Page" ([edit=sysop] (indefinite) [move=sysop] (indefinite)) current
- 14:0414:04, 12 February 2012 diff hist 0 m Main Page Protected "Main Page" ([edit=sysop] (indefinite) [move=sysop] (indefinite))
11 February 2012
- 10:3010:30, 11 February 2012 diff hist +176 N MediaWiki:Common.css Created page with "→CSS placed here will be applied to all skins: →Pad Google AdSense box in portlet in sidebar: #p-googleadsense .pBody { padding-top: 5px; text-align: center; }" current
- 10:1010:10, 11 February 2012 diff hist +7 m MediaWiki:Sidebar No edit summary
- 10:0910:09, 11 February 2012 diff hist +217 N MediaWiki:Sidebar Created page with " * navigation ** mainpage|mainpage-description // ** portal-url|portal ** currentevents-url|currentevents ** recentchanges-url|recentchanges ** randompage-url|randompage ** he..."
10 February 2012
- 22:0222:02, 10 February 2012 diff hist +1,382 m Main Page →Editors
7 February 2012
- 02:5902:59, 7 February 2012 diff hist −236 m Main Page →Welcome to Onco Wiki
- 02:3102:31, 7 February 2012 diff hist +336 N Weekly Carboplatin + Paclitaxel + RT → Carboplatin + Paclitaxel Created page with "== Indication == Concurrent chemoradiation for stage III cancer *Paclitaxel (Taxol) 45-50 mg/m2 iv over 1 h qw x 7 weeks *Carboplatin ACU 2 iv over 30 min qw x 7 weeks *Radio..." current
- 02:3102:31, 7 February 2012 diff hist +354 N Cisplatin + Etoposide + RT → Docetaxel Created page with "== Indication == Concurrent chemoradiation for stage III cancer *Cisplatin 50 mg/m2 iv days 1, 8, 29 and 36 *Etoposide (VP-16) 50 mg/2 iv days 1-5, 29-33 *Radiotherapy 1.8 Gy..." current
- 02:3002:30, 7 February 2012 diff hist −5 m Cancer treatment information No edit summary current
- 02:2702:27, 7 February 2012 diff hist −162 m Main Page No edit summary
- 02:2002:20, 7 February 2012 diff hist −2,993 Talk:Main Page Blanked the page
- 02:1902:19, 7 February 2012 diff hist +124 Guidelines for contributors No edit summary current
- 02:1802:18, 7 February 2012 diff hist −5 m Cytotoxic Regimens →Sections
- 02:1802:18, 7 February 2012 diff hist 0 m XELOX + Bevacizumab 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m XELIRI + Bevacizumab 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Vinorelbine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m VeIP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m VNCOP-B 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m VMPT 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m VIP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m VAD 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Unknown Primary, Carcinoma Of 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m TrophoblasticTumors, Gestational 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Total Therapy 2 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Total Therapy 1 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Topotecan 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Thymoma And Thymic Carcinoma 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Thal/Dex 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Testicular Cancer 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Test spam 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Temsirolimus 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Temozolomide + Thalidomide 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Temozolomide + RT 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Temozolomide + IL-2 + IFN + GM-CSF 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Temozolomide + IFN 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Temozolomide 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Tamoxifen 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m TIP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Sunitinib 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Streptozocin + Doxorubicin 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Streptozocin + 5-FU 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Stem Cell Transplantation 1 revision
- 02:1802:18, 7 February 2012 diff hist 0 m Stanford V 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Standard BEACOPP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Standard3plus7 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Sorafenib 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Satraplatin + Prednisone 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Sarcoma 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Sandbox 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m SMILE 1 revision
- 02:1802:18, 7 February 2012 diff hist 0 m Rituximab, Bendamustine, Bortezomib 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Rituximab 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Rev/Dex 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m RTOG study 93-10 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m RICE 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m RC 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m R-MCP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m R-GemOx 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m R-FCM + maintenance R 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m R-FCM 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m R-EPOCH 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m R-CVP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m R-CHOP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Prostate Cancer 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Prednisone 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Postremission High Dose Cytarabine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Plerixafor and G-CSF 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Pentostatin 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Pemetrexed 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Pegylated liposomal doxorubicin 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Panitumumab 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Pancreatic Cancer 1 revision
- 02:1802:18, 7 February 2012 diff hist 0 m Paclitaxel IV + Cisplatin IP + Paclitaxel IP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Paclitaxel + Gemcitabine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Paclitaxel + Carboplatin + Gemcitabine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Paclitaxel 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m PCV 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m PCR 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m PAD 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m PAC 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Oxaliplatin + Capecitabine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Ovarian Epithelial Cancer 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Octreotide 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Oblimersen + Dacarbazine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Non-Hematological Malignancies 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Nilotinib 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Nasopharyngeal Cancer 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Myelodysplastic Syndromes 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Multiple Myeloma And Plasma Cell Dyscrasias 1 revision
- 02:1802:18, 7 February 2012 diff hist 0 m Mitoxantrone + Prednisone 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Mini-BEAM 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m MiCMA 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Melanoma 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Megestrol acetate 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Malignant Mesothelioma 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Main Page 1 revision
- 02:1802:18, 7 February 2012 diff hist 0 m MVAC 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m MRC UKALL XII/ECOG E2993 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m MPT 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m MP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m MOPPABV Hybrid 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m MOPP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m MINE/ESHAP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m MIME 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m MCP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m MAID 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m MACOP-B 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m M-BACOD 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Lymphoma Non-Hodgkin's, Adult 1 revision
- 02:1802:18, 7 February 2012 diff hist 0 m Lymphoma Hodgkin's, Adult 1 revision
- 02:1802:18, 7 February 2012 diff hist 0 m Luprolide 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Lung Cancer Small Cell 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Lung Cancer Non Small Cell 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Linker Regimen 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Lenalidomide + Rituximab 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Lenalidomide 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m LV + 5-FU + Irinotecan + Bevacizumab 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m LV5FU-P 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m LALA 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Kidney Renal Cell Cancer 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Ketoconazole 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Kaposi's Sarcoma 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Imatinib 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Ifosfamide + Paclitaxel 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Ifosfamide 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m IVE 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m IMVP-16 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m IL-2 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m IFL + Bevacizumab 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m ICE-aml 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m ICE 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m HyperCVADHDMTX-AraC 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m HyperCVAD 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m High dose Methotrexate 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Hepatocellular Cancer Adult, Primary 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Hematological Malignancies 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Hairy Cell Leukemia 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m HAM 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Guidelines on using this site 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Guidelines for contributors 1 revision
- 02:1802:18, 7 February 2012 diff hist 0 m Goserelin + Flutamide + RT 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Goserelin 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Gemtuzumab Ozogamicin 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Gemcitabine + Vinorelbine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Gemcitabine + Paclitaxel 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Gemcitabine + Oxaliplatin 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Gemcitabine + Erlotinib 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Gemcitabine + Docetaxel 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Gemcitabine + Cisplatin + Paclitaxel 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Gemcitabine + Cisplatin 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Gemcitabine + Capecitabine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Gemcitabine + 5-FU + RT 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Gemcitabine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Gefitinib 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Gastric Cancer 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m GVD 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m GEM-Vinorelbine-Pred 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m GEM-P 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Fotemustine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Flutamide 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Fludarabine + Rituximab 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Fludarabine + Prednisone 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Fludarabine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m FUFOX + Cetuximab 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m FP + Surgery +/- FP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m FOLFOX6 + Bevacizumab 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m FOLFOX6 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m FOLFOX4 + Cetuximab 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m FOLFOX4 + Bevacizumab 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m FOLFOX4 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m FOLFOX 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m FOLFIRI + Cetuximab 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m FOLFIRI + Bevacizumab 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m FND 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m FN 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m FLOX 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m FLOFOXIRI 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m FLAG-Ida 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m FLAG 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m FCR 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m FCM 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m FC 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Ewing’s sarcoma and primitive neuroectodermal tumor of bone 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Etoposide + Cisplatin 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Etoposide 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Esophageal Cancer 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Escalated BEACOPP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Erlotinib 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Endometrial Cancer 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m EVAP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m EVA 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m ESHAP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m EPOCH 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m EPIC 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m EP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m ECF + surgery + ECF 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m ECF 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m EBVMm 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m EAPLG 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Doxorubicin + Bleomycin + Vinblastine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Doxorubicin 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Docetaxel + Prednisone 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Docetaxel + Estramustine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Docetaxel 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Dexamethosone 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Dexamethasone 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Dexa-BEAM 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Decitabine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m DaunoXome 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Dasatinib 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Dactinomycin 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Dacarbazine + Cisplatin + Carmustine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Dacarbazine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m DVD 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m DT-PACE 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m DHAX 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m DHAP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m DAT 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cytotoxic Regimens 1 revision
- 02:1802:18, 7 February 2012 diff hist 0 m Cyclophosphamide Bortezomib Dexamethasone 1 revision
- 02:1802:18, 7 February 2012 diff hist 0 m Cyclophosphamide 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Current events 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Colon Cancer 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Clofarabine, cyclophosphamide and etoposide 1 revision
- 02:1802:18, 7 February 2012 diff hist 0 m Cladribine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + Vinorelbine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + Topotecan 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + RT 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + Pemetrexed 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + Paclitaxel 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + Irinotecan + Bevacizumab 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + Irinotecan 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + Gemcitabine + Bevacizumab 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + Gemcitabine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + Etoposide or Vinorelbine or Vinblastine or Vindesine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + Etoposide + RT 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + Etoposide + Bleomycin 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + Etoposide 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + Epirubicin + 5-FU 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + Epirubicin 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + Docetaxel 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + Capecitabine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + 5-FU + RT 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + 5-FU 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Chronic Myelogenous Leukemia 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Chronic Lymphocytic Leukemia 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Chlorambucil + Prednisone 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Chlorambucil 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m ChlVPP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cetuximab + Irinotecan 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cetuximab 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cervical Cancer 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Carmustine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Carcinoid Tumors, Gastrointestinal 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Carboplatin + Vinorelbine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Carboplatin + Pemetrexed 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Carboplatin + Paclitaxel + Etoposide 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Carboplatin + Paclitaxel + Bevacizumab 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Carboplatin + Paclitaxel 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Carboplatin + Irinotecan 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Carboplatin + Gemcitabine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Carboplatin + Etoposide 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Carboplatin + Docetaxel 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Carboplatin 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Capecitabine + RT 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Capecitabine 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CapIri 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Cancer treatment information 1 revision
- 02:1702:17, 7 February 2012 diff hist 0 m CVP 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CVD + IL-2 + IFN 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CVD 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m COPP 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CODOX-M/IVAC 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CNOP 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CMV 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CMF 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CLAG 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CIM 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CHOP-14 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CHOP 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CHOEP-14 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CFAR 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CEP 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CEOP 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CBI 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CB 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CALGB 9710 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CALGB 9111 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CALGB 8811 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CAF 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Breast Cancer 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Brain Tumors Adult 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Bortezomib 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Bonn protocol 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Bladder Cancer 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Bile Duct Cancer Extrahepatic 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Bicalutamide 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m BiRD 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Bevacizumab + IFN 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Bevacizumab + Erlotinib 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Bevacizumab 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Bendamustine + Rituximab 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Bendamustine 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m BFM B-Cell 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m BFM- 95 (German Protocol) 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m BEP 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Azacitidine 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Arsenic Trioxide for relapsed APML 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Arsenic Trioxide for APML, new cases 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Anal Carcinoma 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Amrubicin 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Alemtuzumab + Fludarabine 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Alemtuzumab 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Adriamycin + Cisplatin + Paclitaxel 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Adriamycin + Cisplatin 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Acute Myeloid Leukemia,Adult 1 revision
- 02:1702:17, 7 February 2012 diff hist 0 m Acute Lymphoblastic Leukemia, Pediatric 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Acute Lymphoblastic Leukemia, Adult 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m ATRA plus As203 1 revision
- 02:1702:17, 7 February 2012 diff hist 0 m ASHAP 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m AIDA-PETHEMA Group 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m AI 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m ADOC 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m ADE 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m AD 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m AC 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m ABVD 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m ABDIC 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m A-C-T 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m 5-FU MitomycinC Radiation Therapy Wayne State Regimen 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m 5-FU MitomycinC Radiation Therapy EORTC Regimen 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m 5-FU + RT 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m 5-FU + LV + RT 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m 5-FU + LV + Mitomycin + Dipyridamole 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m 5-FU + LV + Irinotecan 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m 5-FU + LV + Bevacizumab 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m 5-FU + LV 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m 5-FU + Cisplatin + Vinblastine + RT + Surgery 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m 5-FU + Cisplatin + RT + Surgery 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m 5-FU + Cisplatin + RT 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m 5-FU + Cisplatin + Docetaxel 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m 5-FU + Cisplatin 1 revision current
- 02:1702:17, 7 February 2012 diff hist +162 Main Page →Getting started
28 November 2011
- 22:1722:17, 28 November 2011 diff hist +661 Nm Multiple Myeloma And Plasma Cell Dyscrasias →Bortezomib regimens
19 November 2011
- 01:4201:42, 19 November 2011 diff hist +1,539 N SMILE →References
19 September 2011
- 02:0902:09, 19 September 2011 diff hist +3,408 N Bonn protocol →References
15 September 2011
- 12:1412:14, 15 September 2011 diff hist +1,808 N Cyclophosphamide Bortezomib Dexamethasone New page: == Regimen == Bortezomib 1.3 mg/m(2) intravenously on days 1, 4, 8 and 11 Cyclophosphamide 300 mg/m(2) orally on days 1, 8, 15 and 22 Dexamethasone 40 mg orally on days 1-4, 9-12 and 1...
10 September 2011
- 23:4523:45, 10 September 2011 diff hist +2,924 Nm DT-PACE →Reference
7 September 2011
- 02:2802:28, 7 September 2011 diff hist +584 N Rituximab, Bendamustine, Bortezomib New page: ==Regimen== Bortezomib administered intravenously (IV) at a dose of 1.6 mg/m2 on days 1, 8, 15, and 22, cycles one to five; Bendamustine 50, 70, or 90 mg/m2 IV over a 60-minute infusio...
- 02:2302:23, 7 September 2011 diff hist +1,405 N Lymphoma Non-Hodgkin's, Adult →Indolent NHL
1 September 2011
- 04:4704:47, 1 September 2011 diff hist +3,968 N CFAR →References
- 04:4504:45, 1 September 2011 diff hist +834 N Chronic Lymphocytic Leukemia →Single agents
- 04:4304:43, 1 September 2011 diff hist +837 N Bendamustine →Indolent Non-Hodgkin's Lymphoma
13 July 2011
- 09:5509:55, 13 July 2011 diff hist +1,156 Nm BFM B-Cell →Block B
19 April 2011
- 05:5405:54, 19 April 2011 diff hist +699 N Clofarabine, cyclophosphamide and etoposide New page: == Regimen == Clofarabine 40 mg/m2 over 2 h IVI day 1-5 Cyclophosphamide 400 mg/m2 over 1 h day 1-5 Etooside 150 mg/m2 over 2 hr day 1-5 == Supportive == Prophylactic steroids were gi...
- 05:4505:45, 19 April 2011 diff hist +79 Nm Acute Lymphoblastic Leukemia, Pediatric →Relapse
5 April 2011
- 06:1706:17, 5 April 2011 diff hist +721 Nm Plerixafor and G-CSF →Regimen
- 06:1406:14, 5 April 2011 diff hist +169 N Stem Cell Transplantation →Mobilization Protocols
- 03:1403:14, 5 April 2011 diff hist +521 N GEM-Vinorelbine-Pred No edit summary
16 February 2011
- 03:1603:16, 16 February 2011 diff hist +2,063 N Main Page Editors added
29 December 2010
- 22:4522:45, 29 December 2010 diff hist +674 Nm Mitoxantrone + Prednisone Reverted edits by Emrick586899 (Talk); changed back to last version by Dobbs
13 December 2010
- 20:2320:23, 13 December 2010 diff hist +2,257 Nm Capecitabine Reverted edits by Alexander41972 (Talk); changed back to last version by Palmdoc
- 20:2120:21, 13 December 2010 diff hist +1,199 Nm Etoposide Reverted edits by Oswald569191 (Talk); changed back to last version by Palmdoc
22 July 2010
- 22:2822:28, 22 July 2010 diff hist +1,957 N BiRD →Reference
19 July 2010
- 07:4607:46, 19 July 2010 diff hist +1,954 Nm Bendamustine + Rituximab No edit summary
- 02:3902:39, 19 July 2010 diff hist +1,123 N PAD →Reference
- 02:2702:27, 19 July 2010 diff hist +1,402 N Alemtuzumab →[[Chronic_Lymphocytic_Leukemia|Chronic lymphocytic leukemia]]
3 May 2008
- 01:3901:39, 3 May 2008 diff hist +415 Nm Temozolomide + Thalidomide →Indication
5 December 2007
- 03:0303:03, 5 December 2007 diff hist +378 Nm Nasopharyngeal Cancer No edit summary
24 September 2007
- 13:5813:58, 24 September 2007 diff hist +770 N ABDIC No edit summary
- 10:3510:35, 24 September 2007 diff hist +481 N Lymphoma Hodgkin's, Adult No edit summary
7 September 2007
- 04:4304:43, 7 September 2007 diff hist +706 Nm GVD →Regimen
4 September 2007
- 08:3908:39, 4 September 2007 diff hist +3,932 N HyperCVADHDMTX-AraC →Hyper-CVAD
26 August 2007
- 23:1523:15, 26 August 2007 diff hist +10 N Test spam No edit summary
24 August 2007
- 23:3223:32, 24 August 2007 diff hist +546 Nm Guidelines for contributors No edit summary
17 August 2007
- 21:4121:41, 17 August 2007 diff hist +587 Nm TIP →Indication
- 09:0009:00, 17 August 2007 diff hist +2,599 Nm 5-FU + LV →Hepatocellular Carcinoma
15 August 2007
- 08:2208:22, 15 August 2007 diff hist +1,587 N CODOX-M/IVAC →[[Lymphoma_Non-Hodgkin%27s%2C_Adult|Non-Hodgkin's Lymphoma]]
10 August 2007
- 01:5901:59, 10 August 2007 diff hist +1,119 Nm Decitabine →Myelodysplastic syndrome
- 01:5801:58, 10 August 2007 diff hist +1,081 Nm Carmustine →Indications
- 01:5701:57, 10 August 2007 diff hist +1,772 Nm Bortezomib →[Lymphoma_Non-Hodgkin%27s%2C_Adult#Mantle_Cell_Lymphoma|Mantle Cell Lymphoma]]
- 01:5501:55, 10 August 2007 diff hist +1,275 Nm Azacitidine →Indications
9 August 2007
- 07:1307:13, 9 August 2007 diff hist +1,307 Nm Breast Cancer →Chemotherapy
- 03:3203:32, 9 August 2007 diff hist +446 Nm Endometrial Cancer No edit summary
- 03:2203:22, 9 August 2007 diff hist +1,244 Nm 5-FU + Cisplatin →Esophageal Cancer
- 03:1703:17, 9 August 2007 diff hist +1,635 Nm R-CHOP →Regimen
- 03:1503:15, 9 August 2007 diff hist +231 Nm Hairy Cell Leukemia →Single agent
- 03:1203:12, 9 August 2007 diff hist +2,824 N Cladribine No edit summary
- 03:0903:09, 9 August 2007 diff hist +1,359 Nm Fludarabine →[[Chronic_Lymphocytic_Leukemia|Chronic Lymphocytic Leukemia]]
8 August 2007
- 06:0706:07, 8 August 2007 diff hist +1,689 Nm PCV →References
- 05:5705:57, 8 August 2007 diff hist +429 Nm Temozolomide + RT →Anaplastic astrocytoma and glioblastoma
- 01:4201:42, 8 August 2007 diff hist +1,565 Nm Rituximab →Indications
- 01:2701:27, 8 August 2007 diff hist +576 Nm Cytotoxic Regimens →External Links
- 01:2401:24, 8 August 2007 diff hist +483 Nm Cyclophosphamide →[Lymphoma_Non-Hodgkin%27s%2C_Adult#Indolent_NHL|Indolent NHL]]
- 01:2201:22, 8 August 2007 diff hist +164 Nm Cancer treatment information No edit summary
7 August 2007
- 23:0923:09, 7 August 2007 diff hist +552 Nm Brain Tumors Adult No edit summary
- 06:4306:43, 7 August 2007 diff hist +721 N Gemcitabine + Cisplatin + Paclitaxel New page: == Indication == locally advanced or metatstatic bladder cancer *Gemcitabine (Gemzar) 1000 mg/m2 iv over 30-60 min d1, 8 *Cisplatin 70 mg/m2 iv d1 *Paclitaxel (Taxol) 80 mg/m2 iv d1, 8 Q3...
- 06:4106:41, 7 August 2007 diff hist +436 N Gemcitabine + Paclitaxel New page: == Indication == metastatic bladder cancer *Gemcitabine (Gemzar) 1000 mg/m2 iv d1, 8 and 15 *Paclitaxel (Taxol) 200 mg/m2 iv over 3 hrs d1 Q3w x 6 cycles === References === [http://www....
- 05:5105:51, 7 August 2007 diff hist +595 N LV5FU-P New page: == Regimen == *Leucovorin 200 mg/m2 iv over 2 hrs d1 *5-FU 400 mg/m2 iv bolus, followed by 600 mg/m2 iv over 22 hrs, d1 and 2 *Cisplatin 50 mg/m2 iv d2 Q2w == References == [http://annonc...
- 04:0304:03, 7 August 2007 diff hist +653 Nm Pentostatin No edit summary
- 03:2303:23, 7 August 2007 diff hist +2,597 Nm Imatinib No edit summary
- 02:5002:50, 7 August 2007 diff hist +720 N CMF New page: == Indication == Breast cancer == Regimen == *Cyclophosphamide 100 mg/m2/day PO on days 1-14 *Methotrexate 40 mg/m2 IV on days 1 and 8 *5-Fluorouracil 600 mg/m2 IV on days 1 and 8 Repeat...
- 02:4602:46, 7 August 2007 diff hist +1,311 N A-C-T New page: == Regimen == Patients with resected breast cancer involving four or more ipsilateral axillary lymph nodes were treated with nine cycles of chemotherapy, using 14-day intertreatment interv...
6 August 2007
- 23:3923:39, 6 August 2007 diff hist +3,248 N HyperCVAD →References
- 22:4122:41, 6 August 2007 diff hist +212 N CEOP New page: == Regimen == *Cyclophosphamide 750 mg/m2 IV on day 1 *Epirubicin 75 mg/m2 IV on day 1 *Vincristine 1.4 mg/m2 (Max 2mg) on day 1 *Prednisolone 100mg/m2 PO on days 1-5 Repeat cycle every 2...
- 22:3822:38, 6 August 2007 diff hist +316 N Current events New page: * 1. Registration is now open. You need to create a free login account in order to edit pages in Oncowiki. * 2. Call for Editors. If anyone is interested in being an Editor in Oncowiki, pl...
- 21:5321:53, 6 August 2007 diff hist +211 Nm Myelodysplastic Syndromes →Single agents
- 12:5112:51, 6 August 2007 diff hist +2,928 Nm LALA →Regimen
- 12:2212:22, 6 August 2007 diff hist +149 Nm Acute Lymphoblastic Leukemia, Adult No edit summary
- 12:1312:13, 6 August 2007 diff hist +1,809 N CALGB 8811 New page: == Regimen == Course I: Induction (4 wks) *Cyclophosphamide (Cytoxan) 1200 mg/m2 (800 mg/m2 if pts older than 60) iv d1 *Daunorubicine 45 mg/m2/d (30 mg/m2/d if pts older than 60) iv d1-3...
- 12:1012:10, 6 August 2007 diff hist +1,792 Nm Linker Regimen →CNS prophylaxis
- 12:0112:01, 6 August 2007 diff hist +567 N CLAG New page: == Indication == Relapsed or refractory acute myeloid leukemia == Regimen == *Cladribine 5 mg/m2/d iv over 2 hrs d1-5 *Cytarabine (Ara-C) 2 g/m2/d iv over 4 hrs d1-5 *Filgrastim (Neupogen...
- 11:5911:59, 6 August 2007 diff hist +520 Nm Acute Myeloid Leukemia,Adult →Salvage Regimens
- 11:5811:58, 6 August 2007 diff hist +957 Nm Gemtuzumab Ozogamicin No edit summary
- 09:3009:30, 6 August 2007 diff hist +2,650 N Total Therapy 2 New page: == Multiple Myeloma == === Induction === * Cycle 1, VAD Vincristine (0.5 mg/d x 4 d) CI; Adriamycin (10 mg/m2/d x 4 d) CI; Dexamethasone 40 mg PO d 1-4, 9-12, 17-20 * Cycle 2, DCE...
- 09:1509:15, 6 August 2007 diff hist +1,271 N Total Therapy 1 New page: == Multiple Myeloma == === Induction phase === *Cycles 1-3, VAD Vincristine (0.5 mg/d x 4 d) CI; Adriamycin (10 mg/m2/d x 4 d) CI; Dexamethasone 40 mg PO d 1-4, 9-12, 17-20 *Cycle 4...
- 08:5708:57, 6 August 2007 diff hist +555 Nm VMPT No edit summary
- 08:5308:53, 6 August 2007 diff hist +1,374 N Rev/Dex New page: == Multiple Myeloma == === Rev/Dex low dose === Lenalidomide (Revlimid) 25 mg po qd d1-21<br> Dexamethasone (Decadron) 40 mg po d1, 8, 15, 22<br> Q4w ==== References ==== [http://www.asc...
- 08:5008:50, 6 August 2007 diff hist +454 N DVD New page: == Multiple Myeloma == Pegylated liposomal doxorubicin (Doxil) 40 mg/m2 iv d1<br> Vincristine 2 mg iv d1<br> Dexamethasone (Decadron) 40 mg po qd d1-4<br> Q4w === References === [http://...
- 08:4808:48, 6 August 2007 diff hist +487 N VAD New page: == Multiple Myeloma == Vincristine 0.4 mg iv over 30 min qd d1-4<br> Doxorubicin (Adriamycin) 9 mg/m2 iv over 30 min qd d1-4<br> Dexamethasone (Decadron) 40 mg po qd d1-4, 9-12, 17-20<br>...
- 08:4608:46, 6 August 2007 diff hist +1,215 N MPT New page: == Multiple Myeloma == === Melphalan + Prednisone + Thalidomide regimen 1 === Melphalan (Alkeran) 0.25 mg/kg/d po d1-4 q6w x 12 cycles<br> Prednisone 2 mg/kg/d po d1-4 q6w x 12 cycles<br> ...
- 08:4308:43, 6 August 2007 diff hist +2,063 N Thal/Dex New page: == Multiple Myeloma == Thalidomide ((Thalomid) 100-200 mg po qd<br> Dexamethasone (Decadron) 40 mg po qd d1-4, 9-12, 17-20 for odd cycles and d1-4 only for even cycles q4w Thal-Dex was p...
- 08:3408:34, 6 August 2007 diff hist +680 Nm MP No edit summary
- 05:0305:03, 6 August 2007 diff hist +643 Nm Hematological Malignancies No edit summary
5 August 2007
- 23:4923:49, 5 August 2007 diff hist +962 N FC No edit summary
- 23:1123:11, 5 August 2007 diff hist +94 N Chronic Myelogenous Leukemia New page: == Single agents == Imatinib (Gleevec) Dasatinib (Sprycel) Nilotinib (Tasigna)
- 14:5914:59, 5 August 2007 diff hist +5,929 N BFM- 95 (German Protocol) →Regimen
- 14:5414:54, 5 August 2007 diff hist +1,536 Nm Arsenic Trioxide for relapsed APML No edit summary
- 14:4814:48, 5 August 2007 diff hist +643 N 5-FU MitomycinC Radiation Therapy EORTC Regimen New page: == Regimen == * 5-Flurouracil: 750mg/m2/day IV continuous infusion on days 1-5 and 29-33 * Mitomycin-C: 15mg/m2 IV on day 1 * Radiation therapy: 180 cGy/day over 5 week period (tota...
- 14:4314:43, 5 August 2007 diff hist +430 N 5-FU MitomycinC Radiation Therapy Wayne State Regimen New page: == Regimen == * 5-Fluorouracil 1000mg/m2/day continuous infusion on days 1-4 and 29-32 * Mitomycin-C 15mg/m2 IV on day 1 * Radiation therapy: 200cGy/day on days 1-5, 8-12, and 5-19 (...
- 14:4214:42, 5 August 2007 diff hist +381 N Anal Carcinoma No edit summary
- 14:0014:00, 5 August 2007 diff hist +2,879 N EAPLG New page: == Regimen == === Age < 60 and WBC < 10,000/uL === ==== Induction therapy ==== All trans retinoic acid (ATRA) 45 mg/m2 po qd in 2 divided doses d1 till hematologic CR<br> Cytarabine (Ara-...
- 13:5213:52, 5 August 2007 diff hist +2,080 N CALGB 9710 New page: == Regimen == === Induction therapy === All trans retinoic avid (ATRA) 45 mg/m2 po qd in 2 divided doses d1 till hematologic CR<br> Cytarabine (Ara-C) 200 mg/m2/d civi d3-9<br> Daunorubic...
- 13:4113:41, 5 August 2007 diff hist +1,574 N Arsenic Trioxide for APML, new cases New page: == Regimen == === Intravenous arsenic trioxide === Arsenic trioxide was administered by diluting 10 mg/10 ml vials in 500 ml of Dextrose saline for adults infusing it intravenously over 2...
- 13:3813:38, 5 August 2007 diff hist +3,581 N AIDA-PETHEMA Group New page: == Regimen == === Induction therapy === Oral ATRA (45 mg/m2/d), divided into 2 daily doses, until complete hematologic remission, or for a maximum of 90 days<BR> Idarubicin (12 mg/m2/d) ...
- 13:3413:34, 5 August 2007 diff hist +727 N ATRA plus As203 New page: == Regimen == All patients received 25mg/m2 ATRA orally and 0.16mg/kg As2O3 intravenously per day till CR. <BR> Once CR achieved, they were given 3 courses of consolidation chemotherapy a...
- 13:3313:33, 5 August 2007 diff hist +1,718 N Postremission High Dose Cytarabine New page: == Regimen == Cytarabine 3 g per square meter 3-hour infusion every 12 hours (twice daily) on days 1, 3, and 5 for a total of six doses per course Sequential courses no sooner than every...
- 13:3013:30, 5 August 2007 diff hist +1,023 N FLAG-Ida New page: == Regimen == Fludarabine 30 mg/m2 intravenous (i.v.) infusion for 30 min on days 1 to 5 Ara-C 2 g/m2 i.v. infusion (started 4 h after the start of the Fludarabine) for 2 h on days 1 ...
- 13:2713:27, 5 August 2007 diff hist +515 N FLAG New page: == Regimen == Fludarabine 30 mg/m2 IV (30 min) days 1-5<BR> Cytarabine 2000 mg/m2 IV days 1-5 (3.5 hours after fludarabine)<BR> G-CSF 300 mcg sc until hematopoietic recovery<BR> == Refer...
- 13:2613:26, 5 August 2007 diff hist +801 N HAM New page: == Regimen == Cytarabine 3000 mg/m2 bd IVI (3 hr) days 1-3<BR> Mitoxantrone 10 mg/m2 IVI (30 min) days 3-5<BR> == References == [http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retriev...
- 13:2513:25, 5 August 2007 diff hist +414 N ICE-aml New page: == Regimen == Idarubicin 10 mg/m2 IV days 1,3,5<BR> Cytarabine 100 mg/m2 CI days 1-10<BR> Etoposide 100 mg/m2 IV days 1-5<BR> == References == [http://www.ncbi.nlm.nih.gov/entrez/query.f...
- 13:2513:25, 5 August 2007 diff hist +469 N ADE New page: == Regimen == Ara-C 100 mg/m2 12 hourly IV push Days 1-10<BR> Daunorubicin 50 mg/m2 IV push Days 1, 3, 5<BR> Etoposide 100 mg/m2/day 1 hour infusion Days 1-5<BR> == References == [http:/...
- 13:2313:23, 5 August 2007 diff hist +465 N DAT New page: == Regimen == Daunorubicin 50 mg/m2 IV push Days 1, 3, 5<BR> Ara-C 100 mg/m2 12 hourly IV push Days 1-10<BR> Thioguanine 100 mg/m2 12 hourly PO Days 1-10<BR> == References == [http://www...
- 13:2213:22, 5 August 2007 diff hist +1,216 N Standard3plus7 New page: == Regimens == === Variation 1 === Daunorubicin 45-60 mg/m2 IV on days 1-3<BR> Cytarabine 100 mg/m2 CIV on days 1-7 === Variation 2 === Idarubicin 12 mg/m2 IV slow bolus Days 1-3<BR> Ara...
- 11:4711:47, 5 August 2007 diff hist +1,930 N CALGB 9111 New page: == Regimen == Cycle 1 (4 wks) Cyclophosphamide (Cytoxan) 1200 mg/m2 iv d1 Doxorubicin (Adriamycin) 45 mg/m2/d iv d1, 2, 3 Vincristine 2 mg iv d1, 8, 15, 22 Prednisone 60 mg/m2 po or ...
- 11:4111:41, 5 August 2007 diff hist +593 N R-FCM + maintenance R New page: == Regimen == R-FCM followed by Rituximab 375 mg/m2 iv qw x 4 doses at 3 and 9 months == References == [http://www.bloodjournal.org/cgi/content/abstract/108/13/4003 Forstpointner R e...
- 11:3111:31, 5 August 2007 diff hist +951 N RTOG study 93-10 New page: == Regimen == Methotrexate 2500 mg/m2 iv(2-3 h inf) day 1, every other week x 5 (week 1,3,5,7,9)<BR> Folinic acid 20mg p.o. Every 6 h for 12 doses (week 1,3,5,7,9)<BR> Vincristine 1.4 mg/m...
- 11:2911:29, 5 August 2007 diff hist +696 N M-BACOD New page: == Regimen == Methotrexate 200 mg/m2 IV on days 8 and 15<BR> Leucoverin 10 mg/m2 PO every 6 hours for 8 doses beginning 24 hours after methotrexate<BR> Bleomycin 4 u/m2 IV on day 1<BR> Dox...
- 11:2811:28, 5 August 2007 diff hist +817 N MINE/ESHAP New page: == Regimen == === MINE === Ifosfamide 1333 mg/m2 IV (1 hr) days 1-3<BR> with Mesna<BR> Mitoxantrone 8 mg/m2 IV (15 min) day 1<BR> Etoposide 65 mg/m2 IV (1 hr) days 1-3<BR> To be repeated...
- 11:2711:27, 5 August 2007 diff hist +1,304 N VNCOP-B New page: == Regimen == Cyclophosphamide 300 mg/m2 IV Weeks 1, 3, 5, 7 Mitoxantrone 10 mg/m2 IV Weeks 1, 3, 5, 7 Vincristine 2 mg IV Weeks 2, 4, 6, 8 Etoposide 150 mg/m2 IV Weeks 2, 6 Bleomyci...
- 11:2511:25, 5 August 2007 diff hist +771 N MACOP-B New page: == Regimen == Methotrexate 400 mg/m2 IV on weeks 2,6 and 10<BR> Leucovorin 15 mg/m2 PO every 6 hours for 6 doses, beginning 24 hours after methotrexate<BR> Doxorubicin 50 mg/m2 IV on weeks...